VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Newly dignosised type 2 diabetes according to WHO  │ Newly dignosised type 2 diabetes according to WHO  │     100 │
│ criteria.glycated hemoglobin (HbA1c) was more than │ criteria.glycated hemoglobin (HbA1c) was more than │         │
│ 10%                                                │ 10%                                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Seronegative for antibodies against insulin, islet │ Seronegative for antibodies against insulin, islet │     100 │
│ cells and glutamic acid decarboxylase (GAD)        │ cells and glutamic acid decarboxylase (GAD)        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Type 1 diabetes mellitus,presence of autoimmune    │ Type 1 diabetes mellitus,presence of autoimmune    │     100 │
│ diabetes indicated by antibodies to insulin, islet │ diabetes indicated by antibodies to insulin, islet │         │
│ cells, and GAD；                                   │ cells, and GAD                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Gestational diabetes                               │ Gestational diabetes                               │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ patients with heart, liver, or renal function      │ patients with heart, liver, or renal function      │     100 │
│ impairment;presence of severe infections or        │ impairment;presence of severe infections or        │         │
│ cerebrovascular disease                            │ cerebrovascular disease                            │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria        │   Score │
╞═══════════════════════════════════╪══════════════════════╪═════════╡
│ Must have maximum age of 75 Years │ Gestational diabetes │      34 │
├───────────────────────────────────┼──────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ Gestational diabetes │      38 │
╘═══════════════════════════════════╧══════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 93
Average Levenshtein Ratio of individual lines: 81.71428571428571
OverAll Ratio: 87.35714285714286
